Search - tctmd.com

Displaying 461 - 480 of 6692

Sort: Relevancy | Date

Presentation THT 2025

Effects of AtrioVentricular Interval Modulation (AVIM) Therapy in Subjects With Hypertension and Diastolic Dysfunction

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

Overview of Residual Risk and Pathophysiological Targets for Devices to Treat Chronic HF

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

Performance of a Remote Speech Analysis Technology to Detect Worsening Heart Failure Events in Ambulatory Patients With Heart Failure

Presenter: William Abraham

February 12, 2025

Presentation THT 2025

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF)

Presenter: Simon Braumann

February 12, 2025

Presentation THT 2025

Relationship Between Pulmonary Artery Diastolic Pressure and Blood Volume in Supine or Seated Positions

Presenter: Paula Rambarat

February 12, 2025

Presentation THT 2025

Debate: cfDNA Is the Gold Standard for Rejection Screening

Presenter: Shelley Hall

February 12, 2025

Presentation THT 2025

AI Echo's Potential to Transform HF Management

Presenter: Carolyn Lam

February 12, 2025

Presentation THT 2025

HFpEF: Can Image Phenotyping Help for Prognostication and Therapy DEevelopment

Presenter: Jonathan Cunningham

February 12, 2025

Presentation THT 2025

Use of AI-Based Automated Detection of Clinically Significant VHD From Echocardiography

Presenter: Akhil Narang

February 12, 2025

Presentation THT 2025

Impact of Hemodynamic Testing and Pulmonary Artery Pressure Monitoring on HeartMate 3 RPM and Medication Adjustments: RAMP-IT-UP 3 Study

Presenter: Dor Lotan

February 12, 2025

Presentation THT 2025

Controlled Pulmonary Artery Banding for HFrEF (Restore Medical)

Presenter: Sean Pinney

February 12, 2025

Presentation THT 2025

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Presenter: Nir Uriel

February 12, 2025

Presentation THT 2025

Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial

Presenter: Mary Acosta

February 12, 2025

Presentation THT 2025

Atrial Flow Regulator for Controlled Interatrial, Right-to-Left Shunting in Patients With Severe Primary Pulmonary Arterial Hypertension: The AFR PROPHET Registry

Presenter: Jozef Bartunek

February 12, 2025

Presentation THT 2025

Novel Therapeutics in Transplant Management: Belatacept, ECP and Everything in Between

Presenter: Nir Uriel

February 12, 2025

Presentation THT 2025

Lessons Learned From RESHAPE-HF-2: An Imager's Perspective

Presenter: Ralph von Bardeleben

February 12, 2025

Presentation THT 2025

Strengths and Weaknesses of VHD Quantitation in Clinical Research and Daily Practice

Presenter: Rebecca Hahn

February 12, 2025

Presentation THT 2025

Challenges in Designing Collaborative Clinical Therapeutic Trials in HT

Presenter: Jeffrey Teuteberg

February 12, 2025

Presentation THT 2025

Ventricular Remodeling as an Endpoint for HF Trials: Methods, Comparative Precision, Real-World Applicability

Presenter: Joao Cavalcante

February 12, 2025

Presentation THT 2025

Trials and Tribulations of Xeno-Transplant

Presenter: Albert Hicks

February 12, 2025

Advertisement

Effects of AtrioVentricular Interval Modulation (AVIM) Therapy in Subjects With Hypertension and Diastolic Dysfunction

Overview of Residual Risk and Pathophysiological Targets for Devices to Treat Chronic HF

Performance of a Remote Speech Analysis Technology to Detect Worsening Heart Failure Events in Ambulatory Patients With Heart Failure

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF)

Relationship Between Pulmonary Artery Diastolic Pressure and Blood Volume in Supine or Seated Positions

Debate: cfDNA Is the Gold Standard for Rejection Screening

AI Echo's Potential to Transform HF Management

HFpEF: Can Image Phenotyping Help for Prognostication and Therapy DEevelopment

Use of AI-Based Automated Detection of Clinically Significant VHD From Echocardiography

Impact of Hemodynamic Testing and Pulmonary Artery Pressure Monitoring on HeartMate 3 RPM and Medication Adjustments: RAMP-IT-UP 3 Study

Controlled Pulmonary Artery Banding for HFrEF (Restore Medical)

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial

Atrial Flow Regulator for Controlled Interatrial, Right-to-Left Shunting in Patients With Severe Primary Pulmonary Arterial Hypertension: The AFR PROPHET Registry

Novel Therapeutics in Transplant Management: Belatacept, ECP and Everything in Between

Lessons Learned From RESHAPE-HF-2: An Imager's Perspective

Strengths and Weaknesses of VHD Quantitation in Clinical Research and Daily Practice

Challenges in Designing Collaborative Clinical Therapeutic Trials in HT

Ventricular Remodeling as an Endpoint for HF Trials: Methods, Comparative Precision, Real-World Applicability

Trials and Tribulations of Xeno-Transplant

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content